| REGN | Regeneron Pharmaceuticals | Q1 | $8.22 | $7.84 | — | — | $3.03B | $3.40B | — | — | 04/29/2026 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q4 | $12.07 | $9.69 | $11.44 | 18.06% | $3.79B | $3.80B | $3.88B | 2.27% | 01/30/2026 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q3 | $12.46 | $8.84 | $11.83 | 33.82% | $3.72B | $3.59B | $3.75B | 4.47% | 10/28/2025 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q2 | $11.56 | $7.55 | $12.89 | 70.73% | $3.55B | $3.31B | $3.68B | 11.34% | 08/01/2025 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q1 | $9.55 | $8.82 | $8.22 | -6.80% | $3.15B | $3.29B | $3.03B | -7.93% | 04/29/2025 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q4 | $11.86 | $11.19 | $12.07 | 7.86% | $3.43B | $3.75B | $3.79B | 1.04% | 02/04/2025 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q3 | $11.59 | $11.69 | $12.46 | 6.59% | $3.36B | $3.67B | $3.72B | 1.39% | 10/31/2024 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q2 | $10.24 | $10.53 | $11.56 | 9.78% | $3.16B | $3.36B | $3.55B | 5.57% | 08/01/2024 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q1 | $10.09 | $10.10 | $9.55 | -5.45% | $3.16B | $3.22B | $3.15B | -2.33% | 05/02/2024 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q4 | $12.56 | $10.77 | $11.86 | 10.12% | $3.41B | $3.29B | $3.43B | 4.38% | 02/02/2024 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q3 | $11.14 | $10.77 | $11.59 | 7.61% | $2.94B | $3.22B | $3.36B | 4.44% | 11/02/2023 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q2 | $9.77 | $9.92 | $10.24 | 3.23% | $2.86B | $3.01B | $3.16B | 4.92% | 08/03/2023 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q1 | $11.49 | $9.60 | $10.09 | 5.10% | $2.96B | $3.00B | $3.16B | 5.40% | 05/04/2023 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q4 | $23.42 | $10.03 | $12.56 | 25.22% | $4.95B | $3.13B | $3.41B | 9.07% | 02/03/2023 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q3 | $15.37 | $9.52 | $11.14 | 17.02% | $3.45B | $2.88B | $2.94B | 1.94% | 11/03/2022 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q2 | $25.80 | $9.54 | $9.77 | 2.41% | $5.14B | $2.79B | $2.86B | 2.40% | 08/03/2022 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q1 | $9.89 | $10.04 | $11.49 | 14.44% | $2.53B | $2.73B | $2.96B | 8.61% | 05/04/2022 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q4 | $9.53 | $18.11 | $23.72 | 30.98% | $2.42B | $4.47B | $4.95B | 10.78% | 02/04/2022 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q3 | $8.36 | $9.49 | $15.37 | 61.96% | $2.29B | $2.79B | $3.45B | 23.76% | 11/04/2021 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q2 | $7.16 | $17.69 | $25.80 | 45.85% | $1.95B | $3.89B | $5.14B | 32.11% | 08/05/2021 | Get Alert |
| REGN | Regeneron Pharmaceuticals | Q1 | $6.60 | $9.03 | $9.89 | 9.52% | $1.83B | $2.56B | $2.53B | -1.21% | 05/06/2021 | Get Alert |
